Figure 5.
Change in total length of target lesions from baseline up to initial progression for individual patients in concurrent cohort (dose-finding and expansion parts; A) and delayed cohort (dose-finding part only; B).
Change in total length of target lesions from baseline up to initial progression for individual patients in concurrent cohort (dose-finding and expansion parts; A) and delayed cohort (dose-finding part only; B).